论文部分内容阅读
目的研究在急性心肌梗死伴心房颤动中使用胺碘酮的临床价值。方法 80例急性心肌梗死伴心房颤动患者,根据就诊时间分为对照组和观察组,各40例。观察组使用胺碘酮治疗,对照组使用β受体阻滞剂美托洛尔治疗,对比两组患者疾病治疗总有效率及不良反应。结果观察组治疗总有效率高于对照组(P<0.05);不良发应发生率低于对照组(P<0.05)。结论在急性心肌梗死伴心房颤动的治疗中,使用胺碘酮进行治疗能够使疾病的治疗效果得到提高,同时避免不良发应的发生,具有广泛使用的价值。
Objective To study the clinical value of amiodarone in the treatment of acute myocardial infarction with atrial fibrillation. Methods Eighty patients with acute myocardial infarction with atrial fibrillation were divided into control group and observation group according to the time of treatment. The observation group was treated with amiodarone, while the control group was treated with metoprolol, a β-blocker. The total effective rate and adverse reactions of the two groups were compared. Results The total effective rate of observation group was higher than that of control group (P <0.05). The incidence of adverse reactions was lower than that of control group (P <0.05). Conclusions In the treatment of acute myocardial infarction with atrial fibrillation, the use of amiodarone treatment can improve the therapeutic effect of the disease, and avoid the occurrence of adverse reactions, with extensive use of value.